Hexun Biosciences Co., LTD.
Hexun Biosciences Co., LTD.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Preliminary Effectiveness Study of Mesenchymal Stem Cells, HeXell-2020, in Patients With Stable Coronary Artery Disease | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Recruiting | Phase 1 / Phase 2 | 2026-09-29 | NCT07137104 | |
| Safety and Tolerability Study of Mesenchymal Stem Cells, HeXell-2020, in Elderly Subjects With Mild to Moderate Frailty Syndrome | Frailty, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Not yet recruiting | Phase 1 | 2026-09-25 | NCT07144072 |